Related Experiment Video
Updated: May 15, 2026

07:08
A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
Vertical flow immunoassay (VFA) biosensor for a rapid one-step immunoassay
Young Kyoung Oh1, Hyou-Arm Joung, Sanghyo Kim
1Advanced Photonics Research Institute and Department of Photonics & Applied Physics (APRI), Gwangju Institute of Science & Technology, Gwangju, Korea.
Lab on a Chip
|January 11, 2013
Summary
A novel vertical flow immunoassay (VFA) biosensor enables highly sensitive C-reactive protein (hsCRP) detection in just two minutes. This rapid, one-step assay offers improved performance over traditional lateral flow assays.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Immunotechnology
Background:
- High sensitivity C-reactive protein (hsCRP) is a crucial biomarker for inflammation.
- Existing immunoassay methods can be time-consuming or lack sensitivity.
- Rapid and accurate hsCRP detection is vital for timely clinical diagnosis.
Purpose of the Study:
- To develop a highly rapid, one-step immunoassay for hsCRP detection.
- To utilize a vertical flow immunoassay (VFA) biosensor for enhanced sensitivity and speed.
- To compare the performance of the VFA biosensor with traditional lateral flow assay (LFA) systems.
Main Methods:
- Development of a VFA biosensor comprising stacked sample pad, conjugate pad, FTH film, and nitrocellulose (NC) membrane.
- Immobilization of anti-hsCRP and secondary antibodies on the NC membrane.
- Conjugation of anti-hsCRP antibodies with gold nanoparticles (AuNPs) in the conjugate pad.
- Optimization of assay conditions, including hole size and sample volume.
- Detection of hsCRP using the optimized VFA biosensor.
Main Results:
- The VFA biosensor detected hsCRP concentrations ranging from 0.01 to 10 μg mL(-1) within 2 minutes.
- The assay demonstrated a gradual, concentration-dependent signal increase.
- The VFA system exhibited no hook effect within the tested concentration range.
- Performance comparison showed advantages over traditional LFA systems.
Conclusions:
- A highly rapid and sensitive VFA biosensor for hsCRP detection has been successfully developed.
- The VFA biosensor offers a significant improvement in detection speed and performance compared to LFA.
- This technology holds promise for point-of-care diagnostics and rapid inflammation monitoring.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

